HomeCompareTCBP vs O

TCBP vs O: Dividend Comparison 2026

TCBP yields 400.00% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCBP wins by $11437.79M in total portfolio value
10 years
TCBP
TCBP
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full TCBP calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — TCBP vs O

📍 TCBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCBPO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCBP + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCBP pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCBP
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, TCBP beats the other by $6,517,109,455.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCBP + O for your $10,000?

TCBP: 50%O: 50%
100% O50/50100% TCBP
Portfolio after 10yr
$5718.93M
Annual income
$3,833,598,900.25/yr
Blended yield
67.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

TCBP
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-14.7
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCBP buys
0
O buys
0
No recent congressional trades found for TCBP or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCBPO
Forward yield400.00%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$11437.82M$34.2K
Annual income after 10y$7,667,192,697.76$5,102.74
Total dividends collected$11090.87M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: TCBP vs O ($10,000, DRIP)

YearTCBP PortfolioTCBP Income/yrO PortfolioO Income/yrGap
1← crossover$50,700$40,000.00$10,818$608.16+$39.9KTCBP
2$243,782$189,532.71$11,787$741.68+$232.0KTCBP
3$1,112,560$851,713.55$12,946$911.00+$1.10MTCBP
4$4,823,161$3,632,721.39$14,345$1,127.94+$4.81MTCBP
5$19,879,046$14,718,264.42$16,056$1,409.05+$19.86MTCBP
6$77,964,520$56,693,940.88$18,171$1,777.83+$77.95MTCBP
7$291,226,244$207,804,207.46$20,820$2,268.21+$291.21MTCBP
8$1,037,056,355$725,444,273.70$24,188$2,929.90+$1037.03MTCBP
9$3,523,955,262$2,414,304,962.28$28,533$3,837.11+$3523.93MTCBP
10$11,437,824,828$7,667,192,697.76$34,235$5,102.74+$11437.79MTCBP

TCBP vs O: Complete Analysis 2026

TCBPStock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Full TCBP Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this TCBP vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCBP vs SCHDTCBP vs JEPITCBP vs KOTCBP vs MAINTCBP vs STAGTCBP vs ADCTCBP vs NNNTCBP vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.